American Society of Clinical Oncology

SHERPA: White

People

  1. Rosenberg
    Rosenberg
  2. Bajorin
    Bajorin
  3. Ostrovnaya
    Ostrovnaya
  4. Iyer
    Iyer
  5. Regazzi
    Regazzi
  6. Bochner
    Bochner
  7. Funt
    Funt
  8. Teo
    Teo
  9. Al-Ahmadie
    Al-Ahmadie
  10. Dalbagni
    Dalbagni

Groups

  1. Department of Medicine (32)
  2. Epidemiology and Biostatistics (32)
  3. Genitourinary Oncology Service (32)
  4. Solid Tumor Oncology Division (32)
  5. Biostatistics Service (30)
  6. Surgery (17)
  7. Urology (17)
  8. GSK Faculty (13)
  9. Human Oncology and Pathogenesis Program (9)
  10. Graduate Medical Education (8)
Search Within
  1. "Epidemiology and Biostatistics"
  2. "Jonathan Rosenberg"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (6)
Groups
  1. Department of Medicine (32)
  2. Epidemiology and Biostatistics (32)
  3. Genitourinary Oncology Service (32)
  4. Solid Tumor Oncology Division (32)
  5. Biostatistics Service (30)
  6. Surgery (17)

More Groups

People
  1. Jonathan Rosenberg (32)
  2. Dean Bajorin (28)
  3. Irina Ostrovnaya (26)
  4. Gopakumar Iyer (24)
  5. Ashley Regazzi (18)
  6. Hikmat Al-Ahmadie (18)

More People

Years
  1. 2023 (3)
  2. 2022 (5)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (4)
  6. 2018 (6)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. JCO Precision Oncology (1)

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Big data in oncology: Challenges and solutions
    Meeting Abstract

    Shah, N. J.; Bahadur, N.; Niederhausern, A.; Insinga, A.; Shah, I.; West, G.; Ahmad, H.; Martin, S.; Watson, A.; Nichols, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Novel genetic subtypes of urothelial carcinoma with differential outcomes on immune checkpoint blockade
    Journal Article

    Sarfaty, M.; Golkaram, M.; Funt, S. A.; Al-Ahmadie, H.; Kaplan, S.; Song, F.; Regazzi, A.; Makarov, V.; Kuo, F.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC)
    Meeting Abstract

    Teo, M. Y.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Donahue, T. F.; Goh, A. C.; Cha, E. K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of bladder carcinomas with glandular phenotype
    Journal Article

    Almassi, N.; Whiting, K.; Toubaji, A.; Lenis, A. T.; Jordan, E. J.; Won, H.; Regazzi, A. M.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy
    Meeting Abstract

    Wong, J. L.; Knorr, D.; Whiting, K.; Seshan, V. E.; Pietzak, E. J.; Donahue, T. F.; Cha, E. K.; Goh, A. C.; Smith, R.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meeting Abstract

    Lattanzi, M.; Solovyov, A.; Lihm, J.; Quinlan, C.; Whiting, K.; Li, H.; Al-Ahmadie, H. A.; Teo, M. Y.; Aggen, D. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Favorable toxicity of chemoradiation for muscle-invasive bladder cancer in elderly, frail patients
    Meeting Abstract

    Moore, A.; Zhang, Z.; Bochner, B. H.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Funt, S. A.; Bajorin, D. F.; Teo, M. Y.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial
    Journal Article

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H.; Quinlan, C.; Teo, M. Y.; Lee, C. H.; Aggen, D.; Zimmerman, D.; McHugh, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial
    Meeting Abstract

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H. A.; Quinlan, C.; Teo, M. Y.; Kamradt, J.; Khalil, M. F.; Ostrovnaya, I.; McCoy, A. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of extreme responses to anti-PD1/PDL1 checkpoint inhibitors (CPI) in metastatic urothelial cancer (mUC)
    Meeting Abstract

    Teo, M. Y.; Whiting, K.; Mota, J. M.; Li, H.; Regazzi, A. M.; Solit, D. B.; Aggen, D. H.; Lee, C. H.; Funt, S. A.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save